(Q41561618)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600828%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600828%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600828%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

R Bissonnette

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600828%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

C Maari

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600828%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

K Barber

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600828%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

C W Lynde

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600828%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

20 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600828%20AND%20SRC:MED&resulttype=core&format=json

Journal of the European Academy of Dermatology and Venereology

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600828%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600828%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

1576-1581

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600828%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600828%20AND%20SRC:MED&resulttype=core&format=json

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.

28 February 2020

cites work

1 reference

Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays.

21 January 2018

1 reference

Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up

21 January 2018

1 reference

Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis.

21 January 2018

1 reference

Effectiveness of switching between TNF inhibitors in ankylosing spondylitis: data from the NOR-DMARD register

21 January 2018

1 reference

Influence of neutralizing antibodies to adalimumab and infliximab on the treatment of psoriasis.

21 January 2018

1 reference

A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JDV.12943

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600828%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference